← Leaderboards
David Mulholland
University Of California Los Angeles
$3,108,167
Attributed
$4,108,162
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $737K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,608,169 · 3
CDC$1,499,993 · 1
By mechanism
R01$2,035,787 · 1
U01$1,499,993 · 1
R21$434,542 · 1
F32$137,840 · 1
Top collaborators
- Stuart A Aaronson3 shared
- Emanuela Taioli3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tanya I Stoyanova$7,579,166
- Nicholas C. Brecha$17,691,051
- Robert E Reiter$11,316,970
- Joshua Trachtenberg$10,563,573
- Richard T Waldron$679,462
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateInvestigationGeneticCellsAndrogen ReceptorTumor ProgressionResponseReceptor SignalingSignal PathwayPre-ClinicalEpitheliumFda ApprovedResistanceResistance DevelopmentMouse ModelPre-Clinical ModelCancer CellGene TargetingIn VivoIn VitroNeoplasm MetastasisCancer PatientCollaborationsProstate
Grant awards (14)
Assessing the impact of WTC dust exposure on prostate cancer recurrence$499,997
U01 · FY2025 · OH
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.$197,519
R21 · FY2025 · CA · contact PI
Assessing the impact of WTC dust exposure on prostate cancer recurrence$499,998
U01 · FY2024 · OH
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.$237,023
R21 · FY2024 · CA · contact PI
Assessing the impact of WTC dust exposure on prostate cancer recurrence$499,998
U01 · FY2023 · OH
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$376,098
R01 · FY2019 · CA · contact PI
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$387,731
R01 · FY2018 · CA · contact PI
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$387,731
R01 · FY2017 · CA · contact PI
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$387,731
R01 · FY2016 · CA · contact PI
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$108,765
R01 · FY2016 · CA · contact PI
Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells$387,731
R01 · FY2015 · CA · contact PI
Deciphering Beta-Catenin Contributions in Prostate Cance$48,796
F32 · FY2008 · CA · contact PI
Deciphering Beta-Catenin Contributions in Prostate Cance$46,976
F32 · FY2007 · CA · contact PI
Deciphering Beta-Catenin Contributions in Prostate Cance$42,068
F32 · FY2005 · CA